Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Sec. 173 of the Companies Act, 2013 SMS Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on the Saturday, 07th day of August, 2021, at the Registered Office of the Company, for the following items: To consider and approve the Un-audited Financial results of the Company for the First Quarter ended on 30th June, 2021, To consider the board report for the financial year 2020-21, To fix the date of Annual General Meeting for the financial year 2020-21, To consider the request received for reclassification of shareholding from Promoter Category to Public Category pursuant to Regulation 31(A) of SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015. The company has informed that Insider Trading window of the company shall remain closed till 9th August, 2021 and trading will be opened on 10th August, 2021 in view of the above- mentioned Board Meeting.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1504.25 |
Dr. Reddys Lab | 6263.70 |
Cipla | 1406.25 |
Zydus Lifesciences | 948.20 |
Lupin | 1615.85 |
View more.. |